Thomsen J Hansen

Title: Thomsen J Hansen: Innovator in Ophthalmic Research

Introduction

Thomsen J Hansen is a notable inventor based in Havertown, PA (US). He has made significant contributions to the field of ophthalmology, particularly in the development of methods to prevent posterior lens capsule opacification.

Latest Patents

Hansen holds a patent for a "Mitotic inhibitor and method for preventing posterior lens capsule." This invention involves a conjugated cytotoxin designed to prevent after-cataract following extracapsular extraction. The mitotic inhibitor comprises a conjugate containing methotrexate, which is covalently linked to an antibody, such as anticollagen, in a molar ratio of approximately 1:1 to 10:1. This innovative approach allows the mitotic conjugate to be instilled in the anterior or posterior chamber of the eye immediately after lens removal or coated onto an intraocular lens prior to insertion.

Career Highlights

Throughout his career, Hansen has worked with prominent organizations, including the Ophthalmic Research Corporation and Drexel University. His work has focused on advancing techniques and treatments in ophthalmic care, showcasing his dedication to improving patient outcomes.

Collaborations

Hansen has collaborated with esteemed colleagues, including David B Soll and Ihab L Kamel. These partnerships have contributed to the development and refinement of his innovative approaches in the field.

Conclusion

Thomsen J Hansen's contributions to ophthalmology through his patent and collaborative efforts highlight his commitment to innovation in medical research. His work continues to influence the field and improve the lives of patients facing vision challenges.